Tsai Yuan-Ming, Kuo Yen-Shou, Lin Kuan-Hsun, Chen Ying-Yi, Huang Tsai-Wang
Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei City 11490, Taiwan.
Diagnostics (Basel). 2023 Mar 16;13(6):1124. doi: 10.3390/diagnostics13061124.
Navigation bronchoscopy is an emerging technique used to evaluate pulmonary lesions. Using Veran's SPiN electromagnetic navigation bronchoscopy (ENB) and Archimedes virtual bronchoscopy navigation (VBN), this study aimed to compare the accuracy and safety of these procedures for lung lesions and to identify potentially relevant knowledge for the application of artificial intelligence in interventional pulmonology in a single institute. This single-center, retrospective study compared the ENB and VBN results in patients with pulmonary lesions unsuitable for biopsy via percutaneous transthoracic needle biopsy methods. A total of 35 patients who underwent navigation bronchoscopy for pulmonary lesion diagnosis were enrolled. Nineteen patients were stratified in the ENB group, and sixteen were in the VBN group. The mean age of this cohort was 67.6 ± 9.9 years. The mean distance of the lesion from the pleural surface was 16.1 ± 11.7 mm (range: 1.0-41.0 mm), and most lesions were a solid pattern ( = 33, 94.4%). There were 32 cases (91.4%) of pulmonary lesions with an air-bronchus sign. A statistically significant difference was found between pulmonary size and transparenchymal nodule access ( = 0.049 and 0.037, respectively). The navigation success rate was significantly higher in the VBN group (93.8% vs. 78.9%). Moreover, no procedure-related complications or mortality were noted. The radiographic characteristics, such as size or solid component, can affect the selection of the biopsy procedure, either ENB or VBN. Navigation bronchoscopy-guided biopsy demonstrated acceptable accuracy and a good safety profile in evaluating pulmonary lesions when the percutaneous approach was challenging or life threatening.
导航支气管镜检查是一种用于评估肺部病变的新兴技术。本研究使用Veran的SPiN电磁导航支气管镜(ENB)和阿基米德虚拟支气管镜导航(VBN),旨在比较这些检查方法对肺部病变的准确性和安全性,并在单一机构中确定人工智能在介入肺病学应用中的潜在相关知识。这项单中心回顾性研究比较了ENB和VBN在经皮经胸针吸活检方法无法进行活检的肺部病变患者中的结果。共有35例因肺部病变接受导航支气管镜检查以进行诊断的患者入组。19例患者被分层到ENB组,16例在VBN组。该队列的平均年龄为67.6±9.9岁。病变距胸膜表面的平均距离为16.1±11.7毫米(范围:1.0 - 41.0毫米),大多数病变为实性形态(n = 33,94.4%)。32例(91.4%)肺部病变有支气管充气征。在肺部大小和经实质结节进入方面发现有统计学显著差异(分别为P = 0.049和0.037)。VBN组的导航成功率显著更高(93.8%对78.9%)。此外,未观察到与操作相关的并发症或死亡。诸如大小或实性成分等影像学特征可影响活检程序(ENB或VBN)的选择。当经皮途径具有挑战性或危及生命时,导航支气管镜引导下活检在评估肺部病变时显示出可接受的准确性和良好的安全性。